CA3060927A1 - Formulation derivee du cannabis sativa pour la livraison transfermale et transmuqueuse - Google Patents

Formulation derivee du cannabis sativa pour la livraison transfermale et transmuqueuse Download PDF

Info

Publication number
CA3060927A1
CA3060927A1 CA3060927A CA3060927A CA3060927A1 CA 3060927 A1 CA3060927 A1 CA 3060927A1 CA 3060927 A CA3060927 A CA 3060927A CA 3060927 A CA3060927 A CA 3060927A CA 3060927 A1 CA3060927 A1 CA 3060927A1
Authority
CA
Canada
Prior art keywords
cannabis
derived
cbd
cannabis sativa
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3060927A
Other languages
English (en)
Inventor
Tanya Rhodes
Deborah Duffey
Original Assignee
Nuvessl Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/560,342 external-priority patent/US20200078427A1/en
Application filed by Nuvessl Inc filed Critical Nuvessl Inc
Publication of CA3060927A1 publication Critical patent/CA3060927A1/fr
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA3060927A 2018-09-06 2019-11-05 Formulation derivee du cannabis sativa pour la livraison transfermale et transmuqueuse Pending CA3060927A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862727996P 2018-09-06 2018-09-06
US62/727,996 2018-09-06
US16/560,342 2019-09-04
US16/560,342 US20200078427A1 (en) 2018-09-06 2019-09-04 Cannabis Sativa Derived Formulation for Transmucosal and Transdermal Delivery

Publications (1)

Publication Number Publication Date
CA3060927A1 true CA3060927A1 (fr) 2020-03-06

Family

ID=69718613

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3060927A Pending CA3060927A1 (fr) 2018-09-06 2019-11-05 Formulation derivee du cannabis sativa pour la livraison transfermale et transmuqueuse

Country Status (1)

Country Link
CA (1) CA3060927A1 (fr)

Similar Documents

Publication Publication Date Title
US20210401766A1 (en) Method of Using Cannabinoids Encapsulated in Phospholipid Carriers for Transmucosal and Transdermal Administration
US11020355B2 (en) Method of encapsulating cannabinoids in phospholipid carriers
EP3582750B1 (fr) Formulations orales de cannabinoïdes
US20210251948A1 (en) Nanoemulsion hydrophobic substances
RU2418575C2 (ru) Нанолипосома с применением этерифицированного лецитина и способ получения таковой, а также композиция для профилактики или лечения кожных заболеваний, включающая таковые
US20200345656A1 (en) Cannabinoids compositions and methods
US20210093559A1 (en) Self-emulsifying anhydrous intradermal depot gel
EP4054530A1 (fr) Formulation de cannabinoïdes auto-émulsifiante et méthode
US11458092B2 (en) Composition with enhanced passenger molecule loading
CA3070989A1 (fr) Composition comportant une meilleure capacite de charge de molecule passagere et methodes de fabrication et d'utilisation
CA3060927A1 (fr) Formulation derivee du cannabis sativa pour la livraison transfermale et transmuqueuse
CA3060909A1 (fr) Procede d'encapsulation de cannabinoides dans des supports de phospholipides
US20240316075A1 (en) Methods for treatment of pain with cannabinoids
CN104023717B (zh) 包括脂质微胶囊递送媒剂的局部调配物和其用途
US20230355523A1 (en) Self-emulsifying nano-emulsions
US20240366633A1 (en) Methods for treatment of opioid use disorder with cannabinoids
US20210059935A1 (en) Self-emulsifying nano-emulsions
CA3255081A1 (fr) Formes pharmaceutiques pour l’administration de systèmes d’administration de médicament à émulsion autonome
US20260083757A1 (en) Dosage Forms For Delivery Of Self-Emulsifying Drug Delivery Systems
WO2026061592A1 (fr) Formes posologiques pour l'administration de systèmes d'administration de médicament autoémulsifiants
US20210369799A1 (en) Nasal compositions and methods